Clinical Trial Update: A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization [Phase 4]

View source ↗

Summary

A Phase 4 clinical registry is evaluating the safety and effectiveness of an everolimus-eluting stent for coronary revascularization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Everolimus-eluting stent (everolimus-eluting stent)

Snippet

Sponsor: CCRF Consulting Co., Ltd. | Conditions: Coronary Artery Diseases | Phase 4 | Status: UNKNOWN